Impact Factor 6.429

The 5th most cited journal in Immunology

Mini Review ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Immunol. | doi: 10.3389/fimmu.2018.00389

Potential beneficial effects of cytomegalovirus-infection after transplantation

  • 1Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Erasmus University Rotterdam, Netherlands
  • 2Department of Hematology, University Medical Center Utrecht, Netherlands
  • 3Department of Gastroenterology and Hepatology, Erasmus Medical Center, Erasmus University Rotterdam, Netherlands

CMV-infection can cause significant complications after transplantation, but recent emerging data suggest that CMV may paradoxically also exert beneficial effects in two specific allogeneic transplant settings. These potential benefits have been underappreciated, and are therefore highlighted in this review.
Firstly, after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) using T cell and NK cell-replete grafts, CMV-reactivation is associated with protection from leukemic relapse. This association was not observed for other hematologic malignancies This anti-leukemic effect might be mediated by CMV-driven expansion of donor-derived memory-like NKG2C+ NK cells and Vdelta2neg gamma delta T cells. Donor-derived NK cells probably recognize recipient leukemic blasts by engagement of NKG2C with HLA-E and/or by the lack of donor (self) HLA molecules. Vdelta2neg gamma delta T cells probably recognize as yet unidentified antigens on leukemic blasts via their TCR.
Secondly, immunological imprints of CMV-infection, such as expanded numbers of Vdelta2neg gamma delta T cells and terminally differentiated TCRalpha beta+ T cells, as well as enhanced NKG2C gene expression in peripheral blood of operationally tolerant liver transplant patients, suggest that CMV-infection or reactivation may be associated with liver graft acceptance. Mechanistically, poor allo-reactivity of CMV-induced terminally differentiated TCR alpha beta+ T cells and CMV-induced IFN-driven adaptive immune resistance mechanisms in liver grafts may be involved.
In conclusion, direct associations indicate that CMV-reactivation may protect against AML-relapse after allogeneic HSCT, and indirect associations suggest that CMV-infection may promote allograft acceptance after liver transplantation. The causative mechanisms need further investigations, but are probably related to the profound and sustained imprint of CMV-infection on the immune system.

Keywords: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation, solid organ transplantation, Leukemia, tolerance

Received: 01 Nov 2017; Accepted: 12 Feb 2018.

Edited by:

Ulrike Koehl, Hannover Medical School, Germany

Reviewed by:

Anne M. Dickinson, Newcastle University, United Kingdom
Gertjan Lugthart, Leiden University, Netherlands  

Copyright: © 2018 Litjens, van der Wagen, Kuball and Kwekkeboom. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Jaap Kwekkeboom, Erasmus Medical Center, Erasmus University Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands,